Jobs with Startups
JobsStartupsInvestorsMCP
Startups

Multiply Labs

Multiply Labs logo

Multiply Labs

Robotic production capacity for the pharma manufacturing industry

multiplylabs.com
HQ: San Francisco, CA, USA
11-50
Industrials

Company research

Public company, workplace, funding, and market signals

Updated Aug 16, 2026

Overview

Multiply Labs develops cloud-controlled robotic systems that automate manufacturing of individualized and advanced therapies, especially cell therapy and other biomanufacturing workflows, for pharmaceutical and biotech customers.

Primary product

Robotic biomanufacturing systems for cell and gene therapy manufacturing (advanced therapy automation platform)

Headquarters

San Francisco, California, United States

Team size

60-70

Industry

Robotics Engineering

Sub-industry

Biomanufacturing automation / cell and gene therapy manufacturing robotics

Offices

San Francisco, California, United States
Italy (manufacturing subsidiary launched in 2026)

Business model

B2B enterprise hardware/software
commercial system sales
partnerships / pilots with biopharma customers
supply / manufacturing agreements

Funding

Stage

Series A

Total raised

$22.8M

Latest round

Series A · Apr 2021

Latest amount

$20M

Later Stage VC

Sep 2024

Series A

Apr 2021 · Casdin Capital

$20M

Seed Round

Dec 2016

$125K

Corporate Round

Jan 2016

People & investors

Leadership

Fred Parietti

Co-Founder and CEO

Alice Melocchi

CSO

Kevin Liu

VP, Head of Business Operations & People

Lisa Gonzalez

Head of Product

David Hallock

Head of Hardware

Nadia K.

Head of Robotics Software

Angela Lares

Senior Staff Scientist, Head of Bioprocess

Raquel Martin Ibanez

Strategic Alliance Director

Winston Zha

Interim Chief of Staff

Enrico Antonio Racca

General Manager ML Italia & Chief of Supply Chain and Manufacturing ML Inc

Founders

Joe Wilson

Investors

Asia Venture Group
Casdin Capital
Exor
Fifty Years
Founders Fund
Founders Fund / Pathfinder
Garage Capital
Graph Ventures
Lux Capital
P101
Pathfinder
Teradyne Ventures
Y Combinator

Work & culture

Public materials emphasize mission-driven robotics and science, rapid experimentation, and a team of roboticists, engineers, and scientists focused on making personalized therapies scalable.

Compensation

No public compensation bands were found in primary sources. Open roles suggest an active hiring posture, but pay signals are not disclosed publicly.

Product & market

Pricing

Enterprise B2B contracts, pilots, partnerships, and supply agreements; exact pricing not publicly disclosed.

Differentiators

  • —Compatible with existing GMP instruments and workflows
  • —Aims to minimize process modifications and regulatory burden
  • —Cloud-controlled robotic clusters for parallel manufacturing
  • —Uses imitation learning / video-based process capture to automate human expert workflows
  • —Peer-reviewed validation and published cost-reduction results

Technology

AWS
GCP
Nebius
NVIDIA Isaac Sim
NVIDIA GR00T
FoundationPose
FoundationStereo
Ray
Anyscale
Python
Git
React
PyTorch
TensorFlow
Linux
Docker
Grafana
Jira
Slack
Lever

Customers

AstraZeneca
Kyverna Therapeutics
Legend Biotech
Thermo Fisher Scientific
Retro Biosciences
Stanford GMP Facility / Laboratory for Cell and Gene Medicine
Wilson Wolf
GenScript Biotech Corporation
Portal Biotechnologies
Universal Robots

Competitors

Autolomous
Synthego
Cellares
Ori Biotech
Robotics/automation vendors serving cell and gene therapy manufacturing

Scale & contact

Estimated revenue

$1M-$10M

Latest news

Multiply Labs Establishes Italian Manufacturing Subsidiary, Names Former Scuderia Ferrari Leader as Founding General Manager

Multiply Labs · May 2026

Launched Multiply Labs Italia and named Enrico Racca as founding general manager to scale manufacturing for robotic clusters.

Multiply Labs Establishes Italian Manufacturing Subsidiary, Names Former Scuderia Ferrari Leader as Founding General Manager

Multiply Labs newsroom · May 2026

Company launched an Italian manufacturing subsidiary and appointed Enrico Racca to lead it.

Multiply Labs Announces New Collaboration to Automate Cell Therapy Manufacturing with Robotics

Business Wire · Jan 2026

Announced an agreement with AstraZeneca to evaluate GMP-ready robotic systems for commercial-scale cell therapy manufacturing.

Multiply Labs to Bring “Physical AI” Robotics Technology to Advanced Biomanufacturing With NVIDIA

Business Wire · Jan 2026

Announced use of NVIDIA Isaac, GR00T, and perception tooling to accelerate biomanufacturing robotics.

Multiply Labs Expands Collaboration with Thermo Fisher Scientific to Automate Cell Therapy Manufacturing

Multiply Labs · Sep 2025

Expanded partnership to automate Thermo Fisher's DynaCellect magnetic separation workflow and extend cell-therapy automation.

CareersFred Parietti LinkedInGitHubHomepageLinkedIn companyNewsroomPress release: Kaz? / AstraZenecaPress release: KyvernaProductTeam
SourcesMultiply Labs homepageMultiply Labs newsroomBusiness Wire: Series ABusiness Wire: Retro partnershipBusiness Wire: NVIDIA collaborationBusiness Wire: AstraZeneca collaboration

Jobs and careers at Multiply Labs

6 jobs at Multiply Labs

Robotics Engineer

On-site
Milan/Pavia/Turin
2mo ago
On-site
Full-time
Apply

Robotics Field Engineer

On-site
Los Angeles
7mo ago
On-site
Full-time
Apply

VP Software Engineering, Robotics & System

On-site
San Francisco
7mo ago
On-site
Full-time
Apply

Open Applications at Multiply Labs

On-site
San Francisco
10mo ago
On-site
Full-time
Apply

Scientist II

On-site
San Francisco
10mo ago
On-site
Full-time
Apply

Senior / Staff Robotics Research Scientist - Dexterous & Mobile Manipulation

On-site
San Francisco
11mo ago
On-site
Full-time
Apply

Explore startup hiring

Startup Hiring PulseBrowse all startup jobsJobs at Y Combinator startupsJobs at venture-backed startupsIndustrials startup jobs

Jobs with Startups © 2026

Browse jobsMCP guideAboutPowered by Supabase